Detailseite
Projekt Druckansicht

Beendigung von neuropathischen Schmerzen durch Nervenbarriereabdichtung und Netrin-1

Fachliche Zuordnung Anästhesiologie
Anatomie und Physiologie
Förderung Förderung von 2018 bis 2022
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 399489785
 
Erstellungsjahr 2022

Zusammenfassung der Projektergebnisse

Nerves are shielded by three barriers: the perineurium surrounding the nerves, the capillary barrier of vessels within the nerve, and Schwann cells covering neurons and forming the myelin barrier. After nerve trauma all three barriers break down resulting into altered nerve signal conduction. Symptoms include impaired sensation and pain. Netrin-1 is a protein known to regulate the guidance of neurons. Shortly after nerve injury, only low amounts of netrin-1 are produced in the injured nerve. In this project we discovered a new function of netrin-1 as a multitarget barrier stabilizer. If animals are treated with netrin-1 all three barriers can be reconstituted and pain and hypersensitivity resolve. A certain netrin-1 receptor, neogenin, is responsible for this effect. Thus, netrin-1 could be potentially used to foster recovery from nerve damage in patients. Patients with severe neuropathy of different origin indeed have less barrier proteins expressed when nerve biopsies were examined by immunohistochemistry. We think that barrier damage facilitates nerve damage resulting in neurodegeneration and pain. In this context, claudin-12 seems to be a game changer because its presence distinguishes painful from painless neuropathy. We initially hypothesized that netrin-1 fragments promoted barrier opening and full netrin-1 would seal barriers. However, we did not find increased levels of netrin-1 fragments – so this pathway does not seem to be of relevance in nerve barrier breakdown.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung